BSE Live
Dec 10, 16:01Prev. Close
190.10
Open Price
189.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:52Prev. Close
190.11
Open Price
189.61
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
191.21 (20587)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 503.97 | 423.53 | 337.65 | 247.51 | 0.00 | |
| Net CashFlow From Operating Activities | 206.66 | 230.41 | 237.41 | 99.26 | 0.00 | |
| Net Cash Used In Investing Activities | -49.01 | -140.84 | -259.21 | -41.69 | 0.00 | |
| Net Cash Used From Financing Activities | -65.15 | -68.73 | 197.83 | 79.51 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 92.51 | 20.84 | 176.03 | 137.08 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 403.28 | 382.44 | 206.41 | 212.18 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 495.79 | 403.28 | 382.44 | 349.27 | 0.00 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y